Manufacturer
AstraZeneca NDC Codes
Finished products listed with the FDA under labeler names that contain “AstraZeneca”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Truqapcapivasertib | Capivasertib 200 mg/1 | Tablet, Film coatedOral | AstraZeneca Pharmaceuticals LP | 0310-9501 |
| Wainuaeplontersen | Eplontersen 45 mg/.8mL | Injection, SolutionSubcutaneous | AstraZeneca Pharmaceuticals LP | 0310-9400 |
| Wainuaeplontersen | Eplontersen 45 mg/.8mL | Injection, SolutionSubcutaneous | AstraZeneca Pharmaceuticals LP | 0310-9420 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 2.5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6225 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 5 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6250 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 5 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6260 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 10 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6270 |
| Xigduo XRdapagliflozin and metformin hydrochloride | Dapagliflozin propanediol 10 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coated, Extended releaseOral | AstraZeneca Pharmaceuticals LP | 0310-6280 |